These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18057524)

  • 1. Proteomics as a tool for biomarker discovery.
    Kohn EC; Azad N; Annunziata C; Dhamoon AS; Whiteley G
    Dis Markers; 2007; 23(5-6):411-7. PubMed ID: 18057524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer.
    Ryu J; Thomas SN
    Molecules; 2021 May; 26(9):. PubMed ID: 34063568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis for early detection of ovarian cancer: a realistic approach?
    Stevens EV; Liotta LA; Kohn EC
    Int J Gynecol Cancer; 2003; 13 Suppl 2():133-9. PubMed ID: 14656269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets.
    Boyce EA; Kohn EC
    Int J Gynecol Cancer; 2005; 15 Suppl 3():266-73. PubMed ID: 16343243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker discovery in ovarian cancer.
    Tung CS; Wong KK; Mok SC
    Womens Health (Lond); 2008 Jan; 4():27-40. PubMed ID: 19072449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel proteomic technologies to address gaps in pre-clinical ovarian cancer biomarker discovery efforts.
    Jordan HA; Thomas SN
    Expert Rev Proteomics; 2023; 20(12):439-450. PubMed ID: 38116719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and biomarkers for ovarian cancer diagnosis.
    Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
    Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteomics and biomarkers for detection of ovarian cancer].
    Kacerovský M; Tambor V; Lenco J; Tosner J
    Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers.
    Zhang Z; Chan DW
    Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):2995-9. PubMed ID: 20962299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature.
    Posadas EM; Davidson B; Kohn EC
    Curr Opin Oncol; 2004 Sep; 16(5):478-84. PubMed ID: 15314519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples.
    Lopez MF; Mikulskis A; Kuzdzal S; Golenko E; Petricoin EF; Liotta LA; Patton WF; Whiteley GR; Rosenblatt K; Gurnani P; Nandi A; Neill S; Cullen S; O'Gorman M; Sarracino D; Lynch C; Johnson A; Mckenzie W; Fishman D
    Clin Chem; 2007 Jun; 53(6):1067-74. PubMed ID: 17463175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising directions for the diagnosis and management of gynecological cancers.
    Kohn EC; Mills GB; Liotta L
    Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 1():203-9. PubMed ID: 14763176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymes and related proteins as cancer biomarkers: a proteomic approach.
    Liang SL; Chan DW
    Clin Chim Acta; 2007 May; 381(1):93-7. PubMed ID: 17382922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of proteomics in ovarian cancer prevention and treatment.
    Meani F; Pecorelli S; Liotta L; Petricoin EF
    Mol Diagn Ther; 2009; 13(5):297-311. PubMed ID: 19791834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery.
    Swiatly A; Horala A; Matysiak J; Hajduk J; Nowak-Markwitz E; Kokot ZJ
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
    Srivastava A; Creek DJ
    Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular diagnostics of ovarian cancer using proteome techniques].
    Vlasova MA; Moshkovskiĭ SA; Safarova MP; Makarov OV; Archakov AI
    Biomed Khim; 2005; 51(4):367-83. PubMed ID: 16223028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of ovarian cancer.
    Badgwell D; Bast RC
    Dis Markers; 2007; 23(5-6):397-410. PubMed ID: 18057523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.